About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 476 record(s)
Req # A-2023-000217
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-102587-881.Organization: Health Canada
June 2023
Req # A-2023-000283
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-102662-124.Organization: Health Canada
June 2023
Req # A-2023-000289
Adverse Drug Reaction (ADR). Report number: 001033517.Organization: Health Canada
June 2023
Req # A-2023-000311
Adverse Drug Reactions (ADRs). Report numbers: 001018620, 001018334, 001011335, 001015044, 001014046, 001010260, 001017628.Organization: Health Canada
June 2023
Req # A-2023-000316
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-101815-520, Exceptions for the Information Technology Community.Organization: Health Canada
June 2023
Req # A-2023-000329
Adverse Drug Reaction (ADR) for PMS-NITROFURANTOIN. Report number: 001025974.Organization: Health Canada
June 2023
Req # A-2023-000368
Adverse Drug Reaction (ADR) for RIVA-ARIPIPRAZOLE. Report number: 001038374.Organization: Health Canada
June 2023
Req # A-2020-00030
Provide CNSC's own analyses of the International Atomic Energy Agency's review that Canada's rules and regulations for the management of radioactive waste and decommissioning of nuclear facilities fall short, and CNSC's briefing…Organization: Canadian Nuclear Safety Commission
June 2022
Req # A-2020-00051
On the CNSC web page at http://nuclearsafety.gc.ca/eng/waste/high-level-waste/cnsc-role-in-nwmo-apm-project/index.cfm#sec4 the CNSC descrIbes an "Independent advisory group", established by the CNSC in 2013 and composed of Canadian…Organization: Canadian Nuclear Safety Commission
June 2022
Req # A-2021-00014
All briefing materials, including and not limited to briefing notes, information notes, scenario notes, prepared and/or provided to the President in February and March 2021.Organization: Canadian Nuclear Safety Commission
June 2022